Over 24 weeks, 5 mg oral minoxidil did not clearly beat 5% topical minoxidil on the main hair-density measure in men with pattern hair loss.
Type of study
Where this study sits on the evidence spectrum
Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.
Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
R
Randomized and double-blind. Everyone took a pill and used a scalp solution, but only one contained minoxidil. This helped keep participants and study staff from knowing who got which treatment.
At a glance
Who was studied and for how long
Enrolled
90 men
68 completed the study
Length
24 weeks
One clinic in Brazil
Condition
Pattern hair loss
Men ages 18 to 55
Compared
Oral vs topical
5 mg pill vs 5% scalp solution
What they did
How the study worked
Random assignment45 men started in each group.
Pill and solutionOne group took 5 mg by mouth daily. The other applied 1 mL of 5% solution twice daily. Each also received a dummy version of the other treatment.
Hair countsThe study counted thicker hairs at the front and crown of the scalp at baseline and week 24.
What they found
The results
Oral minoxidilTopical minoxidil
Visible improvement at the crown
Share judged improved from photos; this was separate from the main hair-density measure.
Oral minoxidil
70%
Topical minoxidil
46%
Secondary outcome (p = 0.04)
Excess hair growth
Reported in 22 of 45 on oral minoxidil and 11 of 45 on topical minoxidil.
Oral minoxidil
49%
Topical minoxidil
25%
p = 0.02
The main comparison counted thicker hairs per square centimeter. The estimated difference favored the pill by 3.1 thicker hairs per square centimeter at the front (p = 0.27) and 23.4 at the crown (p = 0.09), but both estimates were imprecise. Photos favored the pill at the crown, but that was a separate measure.
Who paid for it
Funding and conflicts of interest
The Brazilian Dermatology Society Support Fund funded the trial and had no role in conducting or reporting it. The lead author reported a grant from the fund.
How much to trust it
Strengths and limits
Strengths
Randomized and double-blind
Compared two active treatments directly
Used standardized scalp images for hair counts
Limits
Only 68 of 90 men completed the study
One clinic, with 24 weeks of follow-up
The trial tested one oral dose and one topical schedule in men
Too small to compare uncommon side effects reliably
Moderate confidence. The blinded comparison was useful, but 22 men did not finish and the hair-count estimates were imprecise.
What it means for you
The takeaway
No clear hair-count winner
The trial did not establish a hair-density advantage for the pill, and excess hair growth was reported more often with it.
These results do not establish that the treatments are equivalent or apply to lower oral doses.
The thicker hairs that make up most visible scalp coverage.
Placebo
A pill or solution that looks like the treatment but has no active drug.
Original source
Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.. JAMA Dermatol. 2024;160(6):600-605.